Loading...
Sandoz Group AG
SDZNY•PNK
HealthcareDrug Manufacturers - Specialty & Generic
$53.51
$0.04(0.07%)
Sandoz Group AG (SDZNY) Stock Overview
Explore Sandoz Group AG’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for SDZNYStats details for SDZNY are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations
Strong Buy
0
Buy
1
Hold
2
Sell
0
Strong Sell
0
Price Targets
Low$0.00
Average$0.00
High$0.00
Company Profile
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. It develops, manufactures, and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services; and anti-infectives, such as active pharmaceutical ingredients and intermediates primarily antibiotics. The company was founded in 1886 and is headquartered in Rotkreuz, Switzerland.
CEO
Mr. Richard Saynor
Employees
22,049
Headquarters
Suurstoffi 14, Rotkreuz
Founded
2023